Overview
Ziphius specializes in the realization of immersive structures and elevation experiences, positioning itself as a creator of extraordinary voyages that transform dreams into reality. The company operates within the entertainment provider sector, focusing on experiential and immersive entertainment solutions.
In the news
- Yesterday, we traded the lab and our desks for the streets of #Ghent. ☀️ In teams, we took on an Urban Hunt: solving clues, making tactical choices and trying to stay one step ahead of the competition. We wrapped up a great afternoon with drinks and bites — and, of course, some discussion about the final scores. 😉 Great teams make great science. At Ziphius, we make #RNA work harder. 🚀 #Ziphius #Teamwork #RNA #Biotech #TeamBuilding
- A Historic Moment for #mRNA Medicine For the first time, an individualized mRNA-based cancer treatment has demonstrated a clear benefit over the current standard of care in a #Phase3 clinical trial. For us at Ziphius, this is more than just good news for #oncology. It is a powerful validation of what RNA technology can achieve: medicines that are programmable, rapidly developed, and increasingly tailored to the individual patient. This breakthrough highlights the enormous potential of RNA as a platform for the medicine of
- In deze podcastaflevering deelt onze CEO Chris Cardon inzichten uit zijn ondernemersparcours: van zijn achtergrond als apotheker, over de oprichting van meerdere bedrijven, tot ervaringen met overnames, financiering en internationale groei. Die combinatie van #wetenschap en #ondernemerschap vormt vandaag ook de basis van Ziphius. De ontwikkeling van een nieuw geneesmiddel lijkt op een #Marathon. We lopen die met een team, met onze aandeelhouders en een massa doorzettingsvermogen. Samen gaan we voor de #Finish. Beluister de
- Today, a total solar eclipse is visible across #Belgium, as the moon moves precisely in front of the sun. At Ziphius, we use #genetics to offer a solution for diseases that remain incurable today. From our genetic research, we build components that fall exactly into place — leaving disease no chance. At Ziphius, we make #RNA work harder. #Ziphius #Biotech #Innovation #saRNA #FutureOfMedicine
- Yesterday the FDA approved #mFLUSIVA: the first flu vaccine built on #mRNA. A milestone — and not just for Moderna. RNA has now stepped out of the "pandemic exception" category, onto an ordinary regulatory path: file, data, decision. At Ziphius we build on exactly those foundations — with a different engine. Conventional #mRNA delivers the instruction once: the cell reads it, produces the antigen, and the signal fades. Our self-amplifying RNA (#saRNA) brings the replication machinery along. The RNA copies itself inside the cell, so
- RNA Day at Ziphius #AUG isn't just the abbreviation for August. It's also the #RNA start codon that tells cells where to begin making proteins. That's why August 1st is World RNA Day. In #RNA labs around the world, it's a tradition: on RNA Day, researchers swap the lab bench for the baking oven. At Ziphius, we happily joined in today. The result: a table full of RNA-inspired creations, and two well-deserved winners — best design and best taste, each rewarded with a trophy (and a riddle to puzzle over). Science, creativity, and
- What happens behind the scenes at Ziphius? What started a few weeks ago with a visit to our site in Zwijnaarde is now a finished report that captures what we do at Ziphius: our science, our technology, and the people behind it. Our mission is to translate cutting-edge science into real solutions for #patients. We appreciate the Trends Kanaal Z team for taking the time to capture that story. Chris Cardon Leonie wyffels #Ziphius #RNA #Biotech #LifeSciences #KanaalZ
Something wrong or missing? Send an update. Fixed within 24 hours.